Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in PACB — Pacific Biosciences Of California, Inc.

CIK 1423053 MIAMI, FL
Back to PACB Full portfolio

Position in PACB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,781,117
+$2,700,730 QoQ
Shares Held
2,845,903
+80.6% QoQ
Ownership
0.916%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 222 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PACB Over Time

Shares Held

Position Value (USD)

Derivatives in PACB

reported options exposure · as of Jun 30, 2026
CallValue
$186,144
CallShares
110,800
PutValue
$109,536
PutShares
65,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $3,554,040,829 across 97 Medical Devices names. PACB ranks #32 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 8,597,227 $780,112,377
2 MDT
Medtronic plc
 5,373,877 $420,398,397
3 EW
Edwards Lifesciences Corp
 3,997,925 $361,652,295
4 ZBH
Zimmer Biomet Holdings, Inc.
 3,477,472 $299,375,563
5 BSX
Boston Scientific Corp
 4,987,748 $212,877,084
6 GKOS
GLAUKOS Corp
 1,390,017 $194,268,775
7 GEHC
GE HealthCare Technologies Inc.
 2,367,032 $151,513,717
8 PEN
Penumbra Inc
 448,763 $141,696,917

All Filings in PACB

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,781,117 2,845,903
2026-06-30 $109,536 65,200
2026-06-30 $186,144 110,800
2026-03-31 $2,080,387 1,576,051
2026-03-31 $258,060 195,500
2026-03-31 $71,148 53,900
2025-12-31 $637,670 341,000
2025-12-31 $5,920,870 3,166,241
2025-12-31 $279,004 149,200
2025-09-30 $299,264 233,800
2025-09-30 $249,600 195,000
2025-09-30 $3,197,892 2,498,354
2025-06-30 $415,276 334,900
2025-06-30 $151,528 122,200
2025-03-31 $140,892 119,400
2025-03-31 $223,256 189,200
2025-03-31 $25 22
2024-12-31 $463,722 253,400
2024-12-31 $660,595 360,981
2024-12-31 $540,216 295,200
2024-09-30 $391,850 230,500
2024-09-30 $166,770 98,100
2024-09-30 $37 22
2024-06-30 $317,018 231,400
2024-06-30 $1,238,755 904,201
2024-06-30 $202,349 147,700
2024-03-31 $394,875 105,300
2024-03-31 $979,500 261,200
2024-03-31 $5,558,681 1,482,315
2023-12-31 $5,341,584 544,504
2023-12-31 $1,430,298 145,800
2023-12-31 $2,549,619 259,900
2023-09-30 $2,293,745 274,700
2023-09-30 $26,258,052 3,144,677
2023-09-30 $1,342,680 160,800
2023-06-30 $3,068,310 230,700
2023-06-30 $52,153,329 3,921,303
2023-06-30 $4,641,700 349,000
2023-03-31 $58,467,095 5,048,972
2023-03-31 $4,139,850 357,500
2023-03-31 $2,940,162 253,900
2022-12-31 $37,437,078 4,576,660
2022-12-31 $2,437,640 298,000
2022-12-31 $2,137,434 261,300
2022-09-30 $379,393 65,300
2022-09-30 $28,673,000 4,935,112
2022-09-30 $233,562 40,200
2022-06-30 $292,604 66,200
2022-06-30 $183,430 41,500
2022-06-30 $1,394,646 315,531

Report a Problem

Category
Description
Email (optional, for follow-up)